Brief: Waverley Pharma Announces Collaboration With Dr. David Herbert And The University Of Manitoba For The Development Of COVID-19 Treatment
25/06/2020 13:24
June 25 (Reuters) - Waverley Pharma Inc WAVE.V :
* WAVERLEY PHARMA ANNOUNCES COLLABORATION WITH DR. DAVID E.
HERBERT AND THE UNIVERSITY OF MANITOBA FOR THE DEVELOPMENT OF A
SYNTHETIC LIBRARY OF CHLOROQUINE ANALOGS TO TREAT COVID-19
Source text for Eikon: ID:nCNWG0G5la
Further company coverage: WAVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Waverley Pharma
See all newsBrief: Waverley Pharma Announces Chief Financial Officer Change
Brief: Waverley Pharma Acquires Us Based Pharmacy
Brief: Waverley Pharma Business Update
Brief: Waverley Pharma Provides Update On Its Parp-1 Inhibitor Program
Brief: Waverley Pharma - Co's Unit Awarded Exclusive Distribution Rights For Two Strengths Of Pemetrexed By NHS England